Sign in
4

Changes in Ownership

Structure Therapeutics Inc. Filed Acc 0001801842-26-000002

Chief Development Officer gave up 4,836 shares (to pay taxes)

From the SEC's structured data for this filing

Trades in this filing

Hall Ashley · Chief Development Officer

Table I: Non-derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2026-03-03 Shares withheld for taxes : show line 1 in the form −4,836 $20.99 $101,508 107,481 D

Table II: Derivative

2 lines
Date Transaction Shares Owned after D/I
2025-05-20 Grant or award : show line 2 in the form American Depositary Shares +225 225 D
2025-11-20 Grant or award : show line 3 in the form American Depositary Shares +237 462 D
Loading xslF345X05/form4-03052026_060304.xml…